A Comprehensive Review on the Chemotherapeutic Potential of Piceatannol for Cancer Treatment, with Mechanistic Insights

Journal of Agricultural and Food Chemistry

Volumn 64, Issue 4, 2016, Pages 725-737

  Seyed, Mohamed Ali ^a,b,c   Jantan, Ibrahim ^a   Bukhari, Syed Nasir Abbas ^a   Vijayaraghavan, Kavitha ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b B S ABDUR RAHMAN CRESCENT INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^c UNIVERSITY OF TABUK   (Saudi Arabia)

Author keywords

cancer inhibition; chemoprevention; piceatannol; resveratrol; therapeutics

Indexed keywords

DISEASE CONTROL; PATHOLOGY; RESVERATROL;

ANTICANCER ACTIVITIES; CARDIO-VASCULAR DISEASE; CHEMOPREVENTION; EPIGALLOCATECHIN GALLATE; PICEATANNOL; THERAPEUTIC INTERVENTION; THERAPEUTIC POTENTIALS; THERAPEUTICS;

DISEASES;

3,3',4,5'-TETRAHYDROXYSTILBENE; ANTINEOPLASTIC AGENT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; HUMANS; NEOPLASMS; STILBENES;

EID: 84956900000     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b05993     Document Type: Review

References (153)

1. Cancer worldwide. In World Cancer Report 2014; Stewart, B. W., Wild, C. P., Eds.; WHO Press: Geneva, Switzerland, 2014; p 16; ISBN 978-92-832-0429-9 http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014.
2. Jemal, A.; Center, M. M.; DeSantis, C.; Ward, E. M. Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol., Biomarkers Prev. 2010, 19, 1893-1907 10.1158/1055-9965.EPI-10-0437
3. de Martel, C.; Ferlay, J.; Franceschi, S.; Vignat, J.; Bray, F.; Forman, D.; Plummer, M. The global burden of cancers attributable to infections in the year 2008: A review and synthetic analysis Lancet Oncol. 2012, 13, 607-615 10.1016/S1470-2045(12)70137-7
4. Irigaray, P.; Newby, J. A.; Clapp, R.; Hardell, L.; Howard, V.; Montagnier, L.; Epstein, S.; Belpomme, D. Lifestyle-related factors and environmental agents causing cancer: An overview Biomed. Pharmacother. 2007, 61, 640-658 10.1016/j.biopha.2007.10.006
5. Seyed, M. A.; Jantan, I.; Vijayaraghavan, K.; Abbas Bukhari, S. N. Betulinic acid: recent advances in chemical modifications, effective delivery, and molecular mechanisms of a promising anticancer therapy. Chem. Biol. Drug Des. 2015, DOI: 10.1111/cbdd.12682.
6. Aggarwal, B. B.; Van Kuiken, M. E.; Iyer, L. H.; Harikumar, K. B.; Sung, B. Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis Exp. Biol. Med. 2009, 234, 825-849 10.3181/0902-MR-78
7. Kerr, J. F.; Wyllie, A. H.; Currie, A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer 1972, 26, 239-257 10.1038/bjc.1972.33
8. Hassan, M.; Watari, H.; AbuAlmaaty, A.; Ohba, Y.; Sakuragi, N. Apoptosis and molecular targeting therapy in cancer BioMed Res. Int. 2014, 2014, 150845 10.1155/2014/150845
9. Richardson, M. A.; Sanders, T.; Palmer, J. L.; Greisinger, A.; Singletary, S. E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology J. Clin. Oncol. 2000, 18, 2505-2514
10. Martin, K. R. Targeting apoptosis with dietary bioactive agents Exp. Biol. Med. (Maywood) 2006, 231, 117-129
11. Kakizoe, T. Chemoprevention of cancer-focusing on clinical trials Jpn. J. Clin.Oncol. 2003, 33, 421-442 10.1093/jjco/hyg090
12. Wattenberg, L. W. What are the critical attributes for cancer chemopreventive agents? Ann. N. Y. Acad. Sci. 1995, 768, 73-81 10.1111/j.1749-6632.1995.tb12111.x
13. Cragg, G. M.; Newman, D. J. Plants as a source of anticancer agents J. Ethnopharmacol. 2005, 100, 72-79 10.1016/j.jep.2005.05.011
14. Mans, D. R.; Rocha, A. B.; Schwartsmann, G. Anti-cancer drug discovery and development in brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds Oncologist 2000, 5, 185-198 10.1634/theoncologist.5-3-185
15. da Rocha, A. B.; Lopes, R. M.; Schwartsmann, G. Natural products in anticancer therapy Curr. Opin. Pharmacol. 2001, 1, 364-369 10.1016/S1471-4892(01)00063-7
16. Warber, S. L.; Seymour, M.; Kaufman, P. B.; Kirakosyan, A.; Cseke, L. J. Modes of action at target sites. Natural Products from Plants; Cseke, L. J.; Kirakosyan, A.; Kaufman, P. B.; Warber, S. L.; Duke, J. A.; Brielmann, H. L., Eds.; CRC Press, Taylor and Francis: Boca Raton, FL, USA, 2006; pp 415-440.
17. Butler, M. S.; Newman, D. J. Mother Nature's gifts to diseases of man: the impact of natural products on antiinfective, anticholestemics and anticancer drug discovery. Progress in Drug Research, Natural Products as Drugs; Peterson, F.; Amstutz, R., Eds.; Birkhauser: Basel, Switzerland, 2008; pp 2-44.
18. Oberlies, N. H.; Kroll, D. J. Camptothecin and taxol: historic achievements in natural products research J. Nat. Prod. 2004, 67, 129-135 10.1021/np030498t
19. Briggs, N. C.; Levine, R. S.; Bobo, L. D.; Haliburton, W. P.; Brann, E. A.; Hennekens, C. H. Wine drinking and risk of non-Hodgkin's lymphoma among men in the United States: A population-based case-control study Am. J. Epidemiol. 2002, 156, 454-462 10.1093/aje/kwf058
20. Crew, K. D.; Neugut, A. I. Epidemiology of upper gastrointestinal malignancies Semin. Oncol. 2004, 31, 450-464 10.1053/j.seminoncol.2004.04.021
21. Schoonen, W. M.; Salinas, C. A.; Kiemeney, L. A.; Stanford, J. L. Alcohol consumption and risk of prostate cancer in middle-aged men Int. J. Cancer 2005, 113, 133-140 10.1002/ijc.20528
22. Wieder, T.; Prokop, A.; Bagci, B.; Essmann, F.; Bernicke, D.; Schulze-Osthoff, K.; Dörken, B.; Schmalz, H. G.; Daniel, P. T.; Henze, G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts Leukemia 2001, 15, 1735-1742 10.1038/sj.leu.2402284
23. Bertelli, A. A.; Das, D. K. Grapes, wines, resveratrol, and heart health J. Cardiovasc. Pharmacol. 2009, 54, 468-476 10.1097/FJC.0b013e3181bfaff3
24. Harmatha, J.; Zídek, Z.; Kmoníčková, E.; Šmidrkal, J. Immunobiological properties of selected natural and chemically modified phenylpropanoids Interdiscip. Toxicol. 2011, 4, 5-10 10.2478/v10102-011-0002-1
25. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 1992, 339, 1523-1526 10.1016/0140-6736(92)91277-F
26. Hung, L. M.; Chen, J. K.; Huang, S. S.; Lee, R. S.; Su, M. J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes Cardiovasc. Res. 2000, 47, 549-555 10.1016/S0008-6363(00)00102-4
27. Hung, L. M.; Chen, J. K.; Lee, R. S.; Liang, H. C.; Su, M. J. Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart Free Radical Biol. Med. 2001, 30, 877-883 10.1016/S0891-5849(01)00474-9
28. Wolter, F.; Clausnitzer, A.; Akoglu, B.; Stein, J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines J. Nutr. 2002, 132, 298-302
29. Sun, H. Y.; Xiao, C. F.; Cai, Y. C.; Chen, Y.; Wei, W.; Liu, X. K.; Lv, Z. L.; Zou, Y. Efficient synthesis of natural polyphenolic stilbenes: resveratrol, piceatannol and oxyresveratrol Chem. Pharm. Bull. 2010, 58, 1492-1496 10.1248/cpb.58.1492
30. Potter, G. A.; Patterson, L. H.; Wanogho, E.; Perry, P. J.; Butler, P. C.; Ijaz, T.; Ruparelia, K. C.; Lamb, J. H.; Farmer, P. B.; Stanley, L. A.; Burke, M. D. The cancer preventative agent resveratrol is converted to the anti-cancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 Br. J. Cancer 2002, 86, 774-778 10.1038/sj.bjc.6600197
31. Piver, B.; Fer, M.; Vitrac, X.; Merillon, J. M.; Dreano, Y.; Berthou, F.; Lucas, D. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes Biochem. Pharmacol. 2004, 68, 773-782 10.1016/j.bcp.2004.05.008
32. Inamori, Y.; Kato, Y.; Kubo, M.; Yasuda, M.; Baba, K.; Kozawa, M. Physiological activities of 3,3′,4,5′-tetrahydroxystilbene isolated from the heartwood of Cassia garrettiana CRAIB Chem. Pharm. Bull. 1984, 32, 213-218 10.1248/cpb.32.213
33. Ko, S. K.; Lee, S. M.; Whang, W. K. Anti-platelet aggregation activity of stilbene derivatives from Rheum undulatum Arch. Pharmacal Res. 1999, 22, 401-403 10.1007/BF02979065
34. Matsuda, H.; Kageura, T.; Morikawa, T.; Toguchida, I.; Harima, S.; Yoshikawa, M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages Bioorg. Med. Chem. Lett. 2000, 10, 323-327 10.1016/S0960-894X(99)00702-7
35. Matsuda, H.; Tomohiro, N.; Hiraba, K.; Harima, S.; Ko, S.; Matsuo, K.; Yoshikawa, M.; Kubo, M. Study on anti-Oketsu activity of rhubarb II. Anti-allergic effects of stilbene components from Rhei undulati rhizoma (dried rhizome of Rheum undulatum cultivated in Korea) Biol. Pharm. Bull. 2001, 24, 264-267 10.1248/bpb.24.264
36. Cantos, E.; Espín, J. C.; Fernández, M. J.; Oliva, J.; Tomás-Barberán, F. A. Postharvest UV-C-irradiated grapes as a potential source for producing stilbene-enriched red wines J. Agric. Food Chem. 2003, 51, 1208-1214 10.1021/jf020939z
37. Rimando, A. M.; Kalt, W.; Magee, J. B.; Dewey, J.; Ballington, J. R. Resveratrol, pterostilbene, and piceatannol in Vaccinium berries J. Agric. Food Chem. 2004, 52, 4713-4719 10.1021/jf040095e
38. Roupe, K.; Teng, X. W.; Fu, X.; Meadows, G. G.; Davies, N. M. Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation Biomed. Chromatogr. 2004, 18, 486-491 10.1002/bmc.342
39. Teguo, P. W.; Decendit, S.; Krisa, S.; Deffieux, G.; Vercauteren, J.; Mérillon, J. M. The accumulation of stilbene glycosides in Vitis vinifera cell suspension cultures J. Nat. Prod. 1996, 59, 1189-1191 10.1021/np9605450
40. Piotrowska, H.; Kucinska, M.; Murias, M. Biological activity of piceatannol: leaving the shadow of resveratrol Mutat. Res., Rev. Mutat. Res. 2012, 750, 60-82 10.1016/j.mrrev.2011.11.001
41. Ferrigni, N. R.; McLaughlin, J. L.; Powell, R. G.; Smith, C. R., Jr. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae J. Nat. Prod. 1984, 47, 347-352 10.1021/np50032a019
42. Lai, T. N.; Herent, M. F.; Quetin-Leclercq, J.; Nguyen, T. B.; Rogez, H.; Larondelle, Y.; André, C. M. Piceatannol, a potent bioactive stilbene, as major phenolic component in Rhodomyrtus tomentosa Food Chem. 2013, 138, 1421-1430 10.1016/j.foodchem.2012.10.125
43. Jeong, S. O.; Son, Y.; Lee, J. H.; Cheong, Y. K.; Park, S. H.; Chung, H. T.; Pae, H. O. Resveratrol analog piceatannol restores the palmitic acid-induced impairment of insulin signaling and production of endothelial nitric oxide via activation of anti-inflammatory and antioxidative heme oxygenase-1 in human endothelial cells Mol. Med. Rep. 2015, 12, 937-944 10.3892/mmr.2015.3553
44. Kimura, Y.; Baba, K.; Okuda, H. Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (part 2) Anticancer Res. 2000, 20, 2923-2930
45. Larrosa, M.; Tomas-Barberan, F. A.; Espin, J. C. The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells Eur. J. Nutr. 2004, 43, 275-284 10.1007/s00394-004-0471-5
46. Kuo, P. L.; Hus, Y. L. The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing as/membrane bound Fas ligand-mediated apoptotic pathway Mol. Nutr. Food Res. 2008, 52, 408-418 10.1002/mnfr.200700252
47. Kim, Y. H.; Park, C.; Lee, J. O.; Kim, G. Y.; Lee, W. H.; Choi, Y. H.; Ryu, C. H. Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases Oncol. Rep. 2008, 19, 961-967 10.3892/or.19.4.961
48. Lee, Y. M.; Lim do, Y.; Cho, H. J.; Seon, M. R.; Kim, J. K.; Lee, B. Y.; Park, J. H. Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity Cancer Lett. 2009, 285, 166-173 10.1016/j.canlet.2009.05.011
49. 2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways Int. J. Biochem. Cell Biol. 2010, 42, 1498-1506 10.1016/j.biocel.2010.05.007
50. Rossi, M.; Caruso, F.; Opazo, C.; Salciccioli, J. Crystal and molecular structure of piceatannol; scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals and docking with transthyretin J. Agric. Food Chem. 2008, 56, 10557-10566 10.1021/jf801923j
51. Moss, R.; Mao, Q.; Taylor, D.; Saucier, C. Investigation of monomeric and oligomeric wine stilbenoids in red wines by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry Rapid Commun. Mass Spectrom. 2013, 27, 1815-1827 10.1002/rcm.6636
52. Kukreja, A.; Wadhwa, N.; Tiwari, A. Therapeutic role of resveratrol and piceatannol in disease prevention J. Blood Disord. Transfus. 2014, 5, 240 10.4172/2155-9864.1000240
53. Bonda, C.; Zhang, J.; Pavlovic, A. The photostability and photostabilization of trans-resveratrol Cosmetics, Toiletries Mag. 2011, 126, 652
54. Aluyen, J. K.; Ton, Q. N.; Tran, T.; Yang, A. E.; Gottlieb, H. B.; Bellanger, R. A. Resveratrol: potential as anticancer agent J. Diet. Suppl. 2012, 9, 45-56 10.3109/19390211.2011.650842
55. Markus, M. A.; Morris, B. J. Resveratrol in prevention and treatment of common clinical conditions of aging Clin. Interv. Aging 2008, 3, 331-339 10.2147/CIA.S3506
56. Galati, G.; O'Brien, P. J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties Free Radical Biol. Med. 2004, 37, 287-303 10.1016/j.freeradbiomed.2004.04.034
57. Clement, M.; Hirpara, J.; Chwadhury, S.; Pervaiz, S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 1998, 92, 996-1002
58. Gautam, S.; Xu, Y.; Dumaguin, M.; Janakiraman, N.; Chapman, R. Resveratrol selectively inhibits leukemia cells: A prospective agent for ex vivo bone marrow purging Bone Marrow Transplant. 2000, 25, 639-645 10.1038/sj.bmt.1702189
59. Farrand, L.; Byun, S.; Kim, J. Y.; Im-Aram, A.; Lee, J.; Lim, S.; Lee, K. W.; Suh, J. Y.; Lee, H. J.; Tsang, B. K. (2013). Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission J. Biol. Chem. 2013, 288, 23740-23750 10.1074/jbc.M113.487686
60. Ahmad, N.; Gupta, S.; Mukhtar, H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappa B in cancer cells versus normal cells Arch. Biochem. Biophys. 2000, 376, 338-346 10.1006/abbi.2000.1742
61. Hsu, S.; Lewis, J.; Borke, J.; Singh, B.; Dickinson, D.; Caughman, G.; Athar, M.; Drake, L.; Aiken, A. C.; Huynh, C. T.; Das, B. R.; Osaki, T.; Schuster, G. S. Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression Anticancer Res. 2001, 21, 3743-3748
62. Liang, D.; Qin, Y.; Zhao, W.; Zhai, X.; Guo, Z.; Wang, R.; Tong, L.; Lin, L.; Chen, H.; Wong, Y. C.; Zhong, Z. S-Allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions Cancer Lett. 2011, 310, 69-76 10.1016/j.canlet.2011.06.019
63. Dirsch, A.; Gerbes, A.; Vollmar, A. Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kB Mol. Pharmacol. 1998, 53, 402-407
64. Palozza, P. Can beta carotene regulate cell growth by a redox mechanism? An answer from cultured cells Biochim. Biophys. Acta, Mol. Basis Dis. 2005, 1740, 215-221 10.1016/j.bbadis.2004.12.008
65. Borek, C. Dietary antioxidants and human cancer Integr. Cancer Ther. 2004, 3, 333-341 10.1177/1534735404270578
66. Singh, B.; Shoulson, R.; Chatterjee, A.; Ronghe, A.; Bhat, N. K.; Dim, D. C.; Bhat, H. K. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways Carcinogenesis 2014, 35, 1872-1880 10.1093/carcin/bgu120
67. Chen, C.; King, A. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological Trends Pharmacol. Sci. 2005, 26, 318-328 10.1016/j.tips.2005.04.004
68. Manson, M.; Farmer, P.; Gescher, A.; Steward, W. Innovative agents in cancer prevention Recent. Results. Cancer. Res. 2005, 166, 257-275 10.1007/3-540-26980-0
69. Philchenkov, A.; Zavelevich, M.; Kroczak, T. J.; Los, M. Caspases and cancer: mechanisms of inactivation and new treatment modalities Exp. Oncol. 2004, 26, 82-97
70. Stennicke, H. R.; Salvesen, G. S. Caspases-controlling intracellular signals by protease zymogen activation Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 2000, 1477, 299-306 10.1016/S0167-4838(99)00281-2
71. Roemer, K.; Mahyar-Roemer, M. The basis for the chemopreventive action of resveratrol Drugs Today 2002, 38, 571-580 10.1358/dot.2002.38.8.820097
72. Hsieh, T. C.; Lin, C. Y.; Lin, H. Y.; Wu, J. M. AKT/mTOR as novel targets of polyphenol piceatannol possibly contributing to inhibition of proliferation of cultured prostate cancer cells ISRN Urol. 2012, 2012, 272697 10.5402/2012/272697
73. Young, L.; Hantz, H.; Martin, K. Resveratrol modulates gene expression associated with apoptosis, proliferation, and cell cycle in cells with mutated human c-Ha-ras, but does not alter c-Ha-ras mRNA or protein expression J. Nutr. Biochem. 2005, 16, 663-674 10.1016/j.jnutbio.2005.03.004
74. Ryoo, H. D.; Bergmann, A. The role of apoptosis-induced proliferation for regeneration and cancer Cold Spring Harbor Perspect. Biol. 2012, 4, a008797 10.1101/cshperspect.a008797
75. Klimowicz, A. C.; Bisson, S. A.; Hans, K.; Long, E. M.; Hansen, H. C.; Robbins, S. M. The phytochemical piceatannol induces the loss of CBL and CBL-associated proteins Mol. Cancer Ther. 2009, 8, 602-614 10.1158/1535-7163.MCT-08-0891
76. Aggarwal, B. B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer Biochem. Pharmacol. 2006, 71, 1397-1421 10.1016/j.bcp.2006.02.009
77. Choi, K. H.; Kim, J. E.; Song, N. R.; Son, J. E.; Hwang, M. K.; Byun, S.; Kim, J. H.; Lee, K. W.; Lee, H. J. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells Cardiovasc. Res. 2010, 85, 836-844 10.1093/cvr/cvp359
78. Ko, H. S.; Lee, H. J.; Kim, S. H.; Lee, E. O. Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NFΚB pathways J. Agric. Food Chem. 2012, 60, 4083-4089 10.1021/jf205171g
79. Kwon, J. Y.; Seo, S. G.; Heo, Y. S.; Yue, S.; Cheng, J. X.; Lee, K. W.; Kim, K. H. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation J. Biol. Chem. 2012, 287, 11566-11578 10.1074/jbc.M111.259721
80. Oliver, J. M.; Burg, D. L.; Wilson, B. S.; McLaughlin, J. L.; Geahlen, R. L. Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol J. Biol. Chem. 1994, 269, 29697-29703
81. Peters, J. D.; Furlong, M. T.; Asai, D. J.; Harrison, M. L.; Geahlen, R. L. Syk, activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it interacts with and phosphorylates alpha-tubulin on tyrosine J. Biol. Chem. 1996, 271, 4755-4762 10.1074/jbc.271.9.4755
82. Sada, K.; Takano, T.; Yanagi, S.; Yamamura, H. Structure and function of Syk protein-tyrosine kinase J. Biochem. 2001, 130, 177-186 10.1093/oxfordjournals.jbchem.a002970
83. Abtahian, F.; Guerriero, A.; Sebzda, E.; Lu, M. M.; Zhou, R.; Mocsai, A.; Myers, E. E.; Huang, B.; Jackson, D. G.; Ferrari, V. A.; Tybulewicz, V.; Lowell, C. A.; Lepore, J. J.; Koretzky, G. A.; Kahn, M. L. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk Science 2003, 299, 247-251 10.1126/science.1079477
84. Seow, C. J.; Chue, S. C.; Wong, W. S. Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro Eur. J. Pharmacol. 2002, 443, 189-196 10.1016/S0014-2999(02)01534-0
85. Geahlen, R. L.; McLaughlin, J. L. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor Biochem. Biophys. Res. Commun. 1989, 165, 241-245 10.1016/0006-291X(89)91060-7
86. Kutil, Z.; Temml, V.; Maghradze, D.; Pribylova, M.; Dvorakova, M.; Schuster, D.; Vanek, T.; Landa, P. Impact of wines and wine constituents on cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase catalytic activity Mediators Inflammation 2014, 2014, 178931 10.1155/2014/178931
87. Murias, M.; Handler, N.; Erker, T.; Pleban, K.; Ecker, G.; Saiko, P.; Szekeres, T.; Jäger, W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship Bioorg. Med. Chem. 2004, 12, 5571-5578 10.1016/j.bmc.2004.08.008
88. Kurumbail, R. G.; Stevens, A. M.; Gierse, J. K.; McDonald, J. J.; Stegeman, R. A.; Pak, J. Y.; Gildehaus, D.; Miyashiro, J. M.; Penning, T. D.; Seibert, K.; Isakson, P. C.; Stallings, W. C. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents Nature 1996, 384, 644-648 10.1038/384644a0
89. Liu, D.; Kim, D. H.; Park, J. M.; Na, H. K.; Surh, Y. J. Piceatannol inhibits phorbol ester-induced NF-kappa B activation and COX-2 expression in cultured human mammary epithelial cells Nutr. Cancer 2009, 61, 855-863 10.1080/01635580903285080
90. Liu, L.; Li, J.; Kundu, J. K.; Surh, Y. J. Piceatannol inhibits phorbol ester-induced expression of COX-2 and iNOS in HR-1 hairless mouse skin by blocking the activation of NFΚB and AP-1 Inflammation Res. 2014, 63, 1013-1021 10.1007/s00011-014-0777-6
91. Gledhill, J. R.; Montgomery, M. G.; Leslie, A. G.; Walker, J. E. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 13632-13637 10.1073/pnas.0706290104
92. Zheng, J.; Ramirez, V. D. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex Biochem. Biophys. Res. Commun. 1999, 261, 499-503 10.1006/bbrc.1999.1063
93. Senior, A. E.; Nadanaciva, S.; Weber, J. The molecular mechanism of ATP synthesis by F1F0-ATP synthase Biochim. Biophys. Acta, Bioenerg. 2002, 1553, 188-211 10.1016/S0005-2728(02)00185-8
94. Zheng, J.; Ramirez, V. D. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals Br. J. Pharmacol. 2000, 130, 1115-1123 10.1038/sj.bjp.0703397
95. Sekiya, M.; Nakamoto, R. K.; Nakanishi-Matsui, M.; Futai, M. Binding of phytopolyphenol piceatannol disrupts β/γ subunit interactions and rate-limiting step of steady-state rotational catalysis in Escherichia coli F1-ATPase J. Biol. Chem. 2012, 287, 22771-22780 10.1074/jbc.M112.374868
96. Sjöberg, B. M. In Nucleic Acids and Molecular Biology; Eckstein, F.; Lilley, D. M. J., Eds.; Springer-Verlag: Berlin, Germany, 1995; Vol. 9, 192-221.
97. Fontecave, M.; Lepoivre, M.; Elleingand, E.; Gerez, C.; Guittet, O. Resveratrol, remarkable inhibitor of ribonucleotide reductase FEBS Lett. 1998, 421, 277-279 10.1016/S0014-5793(97)01572-X
98. Ovesná, Z.; Kozics, K.; Bader, Y.; Saiko, P.; Handler, N.; Erker, T.; Szekeres, T. Antioxidant activity of resveratrol, piceatannol and 3,3′,4,4′,5,5′-hexahydroxy-trans-stilbene in three leukemia cell lines Oncol. Rep. 2006, 16, 617-624 10.3892/or.16.3.617
99. Fritzer-Szekeres, M.; Savinc, I.; Horvath, Z.; Saiko, P.; Pemberger, M.; Graser, G.; Bernhaus, A.; Ozsvar-Kozma, M.; Grusch, M.; Jaeger, W.; Szekeres, T. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells-synergism with Ara-C Int. J. Oncol. 2008, 33, 887-892 10.3892/ijo-00000077
100. Eder, K.; Mikulski, D.; Molski, M. Quantum-chemical study on the thermodynamical aspect of competitive inhibition of ribonucleotide reductase by trans-resveratrol, trans-piceatannol and hydroxyurea Lett. Drug Design Discov. 2015, 12, 93-102 10.2174/1570180811666140909005756
101. Tang, Y. L.; Chan, S. W. A review of the pharmacological effects of piceatannol on cardiovascular diseases Phytother. Res. 2014, 28, 1581-1588 10.1002/ptr.5185
102. Kukreja, A.; Tandon, S.; Mishra, A.; Tiwari, A. Piceatannol: A potential futuristic natural stilbene as fetal haemoglobin inducer J. Clin. Diagn. Res. 2013, 7, 3028-3031 10.7860/JCDR/2013/6239.3839
103. Honma, H.; Podratz, J. L.; Windebank, A. J. Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy J. Peripher. Nerv. Syst. 2003, 8, 65-74 10.1046/j.1529-8027.2003.03009.x
104. Tolkovsky, A. Apoptosis in diabetic neuropathy Int. Rev. Neurobiol. 2002, 50, 145-159 10.1016/S0074-7742(02)50076-3
105. Sharifi, A. M.; Eslami, H.; Larijani, B.; Davoodi, J. Involvement of caspase-8, -9, and -3 in high glucose-induced apoptosis in PC12 cells Neurosci. Lett. 2009, 459, 47-51 10.1016/j.neulet.2009.03.100
106. Rees, D. A.; Alcolado, J. C. Animal models of diabetes mellitus Diabetic Med. 2005, 22, 359-370 10.1111/j.1464-5491.2005.01499.x
107. Minakawa, M.; Miura, Y.; Yagasaki, K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice Biochem. Biophys. Res. Commun. 2012, 422, 469-475 10.1016/j.bbrc.2012.05.017
108. Chang, J. K.; Hsu, Y. L.; Teng, I. C.; Kuo, P. L. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production Eur. J. Pharmacol. 2006, 551, 1-9 10.1016/j.ejphar.2006.08.073
109. Matsui, Y.; Sugiyama, K.; Kamei, M.; Takahashi, T.; Suzuki, T.; Katagata, Y. Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis J. Agric. Food Chem. 2010, 58, 11112-11118 10.1021/jf102650d
110. Manson, M.; Farmer, P.; Gescher, A.; Steward, W. Innovative agents in cancer prevention Recent Results Cancer Res. 2005, 166, 257-275 10.1007/3-540-26980-0-17
111. Narayanan, B.; Narayanan, N.; Stoner, G.; Bullock, B. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants Life Sci. 2002, 70, 1821-1839 10.1016/S0024-3205(02)01481-9
112. Lee, E.; Min, H.; Park, H.; Chung, H.; Kim, S.; Han, Y.; Lee, S. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-49-bromo-cis-stilbene, in human lung cancer cells Life Sci. 2004, 75, 2829-2839 10.1016/j.lfs.2004.07.002
113. Roy, P.; Madan, E.; Kalra, N.; Nigam, N.; George, J.; Ray, R. S.; Hans, R. K.; Prasad, S.; Shukla, Y. Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-kappaB pathway in human epidermoid carcinoma A431 cells Biochem. Biophys. Res. Commun. 2009, 384, 215-220 10.1016/j.bbrc.2009.04.100
114. Dhanalakshmi, S.; Singh, R.; Agarwal, C.; Agarwal, R. Silibinin inhibits constitutive and TNF alpha-induced activation of NF-kB andsensitizes human prostate carcinoma DU145 cells to TNF alpha-induced apoptosis Oncogene 2002, 21, 1759-1767 10.1038/sj.onc.1205240
115. Furukawa, F.; Nishikawa, A.; Chihaza, T.; Shimpo, K.; Beppu, H.; Kuruya, H.; Lee, I.; Hirose, M. Chemopreventive effects of Aloe arborescens on N-nitrobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters Cancer Lett. 2002, 178, 117-122 10.1016/S0304-3835(01)00840-0
116. Wesołowska, O.; Kuzdzał, M.; Strancar, J.; Michalak, K. Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes Biochim. Biophys. Acta, Biomembr. 2009, 1788, 1851-1860 10.1016/j.bbamem.2009.06.005
117. Larrosa, M.; Tomas-Barberan, F. A.; Espin, J. C. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells J. Agric. Food Chem. 2003, 51, 4576-4584 10.1021/jf030073c
118. Barton, B. E.; Karras, J. G.; Murphy, T. F.; Barton, A.; Huang, H. F. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines Mol. Cancer Ther. 2004, 3, 11-20
119. Ferreira, M. J.; Duarte, N.; Gyemant, N.; Radics, R.; Cherepnev, G.; Varga, A.; Molnar, J. Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells Anticancer Res. 2006, 26, 3541-3546
120. Kita, Y.; Miura, Y.; Yagasaki, K. Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells J. Biomed. Biotechnol. 2012, 2012, 672416 10.1155/2012/672416
121. Schneider, Y.; Vincent, F.; Duranton, B.; Badolo, L.; Gossé, F.; Bergmann, C.; Seiler, N.; Raul, F. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells Cancer Lett. 2000, 158, 85-91 10.1016/S0304-3835(00)00511-5
122. Ashikawa, K.; Majumdar, S.; Banerjee, S.; Bharti, A. C.; Shishodia, S.; Aggarwal, B. B. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation J. Immunol. 2002, 169, 6490-6497 10.4049/jimmunol.169.11.6490
123. Hakimuddin, F.; Paliyath, G.; Meckling, K. Treatment of MCF-7 breast cancer cells with a red grape wine polyphenol fraction results in disruption of calcium homeostasis and cell cycle arrest causing selective cytotoxicity J. Agric. Food Chem. 2006, 54, 7912-7923 10.1021/jf060834m
124. Jang, Y. J.; Kim, J. E.; Kang, N. J.; Lee, K. W.; Lee, H. J. Piceatannol attenuates 4-hydroxynonenal-induced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase Ann. N. Y. Acad. Sci. 2009, 1171, 176-182 10.1111/j.1749-6632.2009.04727.x
125. Kim, H. J.; Lee, K. W.; Lee, H. J. Protective effects of piceatannol against beta-amyloid-induced neuronal cell death Ann. N. Y. Acad. Sci. 2007, 1095, 473-482 10.1196/annals.1397.051
126. Kim, H. J.; Lee, K. W.; Kim, M. S.; Lee, H. J. Piceatannol attenuates hydrogen-peroxide- and peroxynitrite-induced apoptosis of PC12 cells by blocking down-regulation of Bcl-XL and activation of JNK J. Nutr. Biochem. 2008, 19, 459-466 10.1016/j.jnutbio.2007.06.001
127. Kim, E. J.; Park, H.; Park, S. Y.; Jun, J. G.; Park, J. H. Treatment of MCF-7 breast cancer cells with a red grape wine polyphenol fraction results in disruption of calcium homeostasis and cell cycle arrest causing selective cytotoxicity J. Med. Food 2009, 12, 943-951 10.1089/jmf.2008.1341
128. Kwon, G. T.; Jung, J. I.; Song, H. R.; Woo, E. Y.; Jun, J. G.; Kim, J. K.; Her, S.; Park, J. H. Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling J. Nutr. Biochem. 2012, 23, 228-238 10.1016/j.jnutbio.2010.11.019
129. Walter, A.; Etienne-Selloum, N.; Brasse, D.; Khallouf, H.; Bronner, C.; Rio, M. C.; Beretz, A.; Schini-Kerth, V. B. Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis FASEB J. 2010, 24, 3360-3369 10.1096/fj.09-149419
130. Lee, H. H.; Park, S. A.; Almazari, I.; Kim, E. H.; Na, H. K.; Surh, Y. J. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling Arch. Biochem. Biophys. 2010, 501, 142-150 10.1016/j.abb.2010.06.011
131. Szlosarek, P. W.; Balkwill, F. R. Tumour necrosis factor alpha: A potential target for the therapy of solid tumours Lancet Oncol. 2003, 4, 565-573 10.1016/S1470-2045(03)01196-3
132. Grell, M.; Douni, E.; Wajant, H.; Löhden, M.; Clauss, M.; Maxeiner, B.; Georgopoulos, S.; Lesslauer, W.; Kollias, G.; Pfizenmaier, K.; Scheurich, P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor Cell 1995, 83, 793-802 10.1016/0092-8674(95)90192-2
133. Mochizuki, S.; Okada, Y. ADAMs in cancer cell proliferation and progression Cancer Sci. 2007, 98, 621-628 10.1111/j.1349-7006.2007.00434.x
134. Liu, W. H.; Chang, L. S. Suppression of Akt/Foxp3-mediated miR-183 expression blocks Sp1-mediated ADAM17 expression and TNFα-mediated NFκB activation in piceatannol-treated human leukemia U937 cells Biochem. Pharmacol. 2012, 84, 670-680 10.1016/j.bcp.2012.06.007
135. Seals, D. F.; Courtneidge, S. A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions Genes Dev. 2003, 17, 7-30 10.1101/gad.1039703
136. Elcheva, I.; Goswami, S.; Noubissi, F. K.; Spiegelman, V. S. CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation Mol. Cell 2009, 35, 240-246 10.1016/j.molcel.2009.06.007
137. Kang, C. H.; Moon, D. O.; Choi, Y. H.; Choi, I. W.; Moon, S. K.; Kim, W. J.; Kim, G. Y. Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation Toxicol. In Vitro 2011, 25, 605-612 10.1016/j.tiv.2010.12.006
138. Thorburn, A. Death receptor-induced cell killing Cell. Signalling 2004, 16, 139-144 10.1016/j.cellsig.2003.08.007
139. Buharalioglu, C. K.; Song, C. Y.; Yaghini, F. A.; Ghafoor, H. U.; Motiwala, M.; Adris, T.; Estes, A. M.; Malik, K. U. Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation Am. J. Physiol. Heart. Circ. Physiol. 2011, 301, H1043-H1055 10.1152/ajpheart.01018.2010
140. Carmeliet, P. Angiogenesis in life, disease and medicine Nature 2005, 438, 932-936 10.1038/nature04478
141. Millauer, B.; Wizigmann-Voos, S.; Schnürch, H.; Martinez, R.; Møller, N. P.; Risau, W.; Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis Cell 1993, 72, 835-846 10.1016/0092-8674(93)90573-9
142. Chintalgattu, V.; Nair, D. M.; Katwa, L. C. Cardiac myofibroblasts: A novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR J. Mol. Cell. Cardiol. 2003, 35, 277-286 10.1016/S0022-2828(03)00006-3
143. Yoo, M. Y.; Oh, K. S.; Lee, J. W.; Seo, H. W.; Yon, G. H.; Kwon, D. Y.; Kim, Y. S.; Ryu, S. Y.; Lee, B. H. Vasorelaxant effect of stilbenes from rhizome extract of rhubarb (Rheum undulatum) on the contractility of rat aorta Phytother. Res. 2007, 21, 186-189 10.1002/ptr.2042
144. Crozier, A.; Jaganath, I. B.; Clifford, M. N. Dietary phenolics: chemistry, bioavailability and effects on health Nat. Prod. Rep. 2009, 26, 1001-1043 10.1039/b802662a
145. Lin, H. S.; Tringali, C.; Spatafora, C.; Wu, C.; Ho, P. C. A simple and sensitive HPLC-UV method for the quantification of piceatannol analog trans-3,5,3′,4′-tetramethoxystilbene in rat plasma and its application for a pre-clinical pharmacokinetic study J. Pharm. Biomed. Anal. 2010, 51, 679-684 10.1016/j.jpba.2009.09.024
146. Robak, T.; Robak, E. Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders Expert Opin. Invest. Drugs 2012, 21, 921-947 10.1517/13543784.2012.685650
147. Koerber, R. M.; Held, S. A.; Heine, A.; Kotthoff, P.; Daecke, S. N.; Bringmann, A.; Brossart, P. Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma Exp. Hematol. Oncol. 2015, 4, 21 10.1186/s40164-015-0016-z
148. Catalgol, B.; Batirel, S.; Taga, Y.; Ozer, N. K. Resveratrol: French paradox revisited Front. Pharmacol. 2012, 3, 141 10.3389/fphar.2012.00141
149. Ko, Y. J.; Kim, H. H.; Kim, E. J.; Katakura, Y.; Lee, W. S.; Kim, G. S.; Ryu, C. H. Piceatannol inhibits mast cell-mediated allergic inflammation Int. J. Mol. Med. 2013, 31, 951-958 10.3892/ijmm.2013.1283
150. Geahlen, R. L.; McLaughlin, J. L. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor Biochem. Biophys. Res. Commun. 1989, 165, 241-245 10.1016/0006-291X(89)91060-7
151. Maggiolini, M.; Recchia, A. G.; Bonofiglio, D.; Catalano, S.; Vivacqua, A.; Carpino, A.; Rago, V.; Rossi, R.; Andò, S. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor α in human breast cancer cells J. Mol. Endocrinol. 2005, 35, 269-281 10.1677/jme.1.01783
152. Raj, L.; Ide, T.; Gurkar, A. U.; Foley, M.; Schenone, M.; Li, X.; Tolliday, N. J.; Golub, T. R.; Carr, S. A.; Shamji, A. F.; Stern, A. M.; Mandinova, A.; Schreiber, S. L.; Lee, S. W. Selective killing of cancer cells by a small molecule targeting the stress response to ROS Nature 2011, 475, 231-234 10.1038/nature10167
153. Halliwell, B. Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc. Res. 2007, 73, 341-347 10.1016/j.cardiores.2006.10.004